AXGC DIALOGUES
LIVE

Serial Number

79370348

Owner

POPVAX PRIVATE LIMITED

Attorney

Lauren K. Tagarao

Filing Date

Nov 10, 2022

Add to watchlist:

No watchlists yet
View on USPTO

AXGC DIALOGUES Trademark

Serial Number: 79370348 • Registration: 7942988

AXGC DIALOGUES is a trademark filed by POPVAX PRIVATE LIMITED on November 10, 2022. The trademark is classified under Class 9 (Computers & Electronics), Class 38 (Telecommunications), Class 41 (Education & Entertainment), Class 16 (Paper Goods), Class 25 (Clothing). The application is currently registered and active.

Owner Contact Info

POPVAX PRIVATE LIMITED (14 trademarks)

8c lohtse chs, millitary road,

Entity Type: 99

Trademark Details

Filing Date

November 10, 2022

Registration Date

September 16, 2025

Published for Opposition

July 29, 2025

Goods & Services

Downloadable software for use in designing, modelling, analysis, data analysis, data management, modification, prediction, and optimization of structure, function, sequence, dynamics, stability, and thermodynamics of nucleic acids, polynucleotides, oligonucleotides, proteins, antigens, immunogens, antibodies, nanobodies, drug conjugates, ligands, peptides, amino acids, nucleotides, nucleosides, carbohydrates, adjuvants, drug delivery carriers, lipids, polymers, and formulations, downloadable software for creating, managing, analyzing, and processing data related to research, development, and manufacturing of pharmaceutical and biopharmaceutical preparations for use in the fields of healthcare, disease management; downloadable software for controlling, optimization, calibration, maintenance, diagnostics, and troubleshooting of bioprocess systems, equipments, tools, and apparatus namely mixing devices, microfluidic devices, micro-mixing devices, mixing vessels, filtration systems, fermenters or bioreactors, liquid handling systems, separation systems, purification systems, chromatography systems, formulation systems, analytical systems, characterization systems, filling system, lyophilisation system, spray drying system, encapsulation system, pumps, pressure vessels, sensors, actuators, flow controllers, control system for fluidics, automated control systems, robotic systems, synthesis systems, and thermocyclers, downloadable software for use in designing, modelling, analysis, data analysis, data management, modification, prediction, and optimization of experiments related to molecular biology, cell biology, biochemistry, organic chemistry, inorganic chemistry, biophysics, immunology, sequencing, toxicology, pharmacodynamics, pharmacokinetics, biodistribution, formulation, drug delivery, bioassays, analytical assays, analytical characterization, immunological assays, and neutralization assays for production or manufacturing of pharmaceutical and biopharmaceutical preparations for use in the fields of management of health or disease;pre- recorded audio-visual and multimedia products in the nature of cassettes, audiotapes, videotapes, CDs, DVDs, CD-ROMs, high-capacity optical discs, and portable storage devices in the fields of healthcare, disease management, pharmaceuticals and medical developments; downloadable podcasts in the field of pharmaceuticals, vaccines, medicines, biologics, biotherapeutics and biosimilars

Clothing, namely, jackets, jerseys, shirts, t-shirts; Indian ethnic wear, namely, kurta, kurti; Clothing, namely, pyjama, aprons, lab coats, scarfs, pants, shorts, blazers, wristbands, gloves, fingerless gloves, socks, bandana, arm sleeves worn separate and apart from blouses, shirts and other tops, clothing belts, capes, knitwear in the nature of knitted tops, jerseys, t-shirts, jumpers in the nature of coveralls, pullovers, cardigans, scarfs, socks, headbands, hoodies, hats, foulards being clothing, neckerchief, scarf, face masks being headwear, sportswear in the nature of sweatpants, swimwear, athletic wear in the nature of shorts and t-shirts, footwear; headgear, namely, hats, knitted caps, and visors; headwear, t-shirts, jackets, jerseys being clothing, caps being headwear, aprons.

Communications by computer terminals; communications by fibre optic networks; providing online forums; streaming of data; live streaming of events through telecommunication means; transmission of podcasts; wireless broadcasting; communications and telecommunications, namely, transmission of podcasts, transmission of voice, data, graphics, images, audio and video by means of telecommunications networks, wireless communication networks, and the internet in the field of health, pharmaceuticals, vaccines, medicines, biologics, biotherapeutics, and biosimilars; transmission of information for others relating to health, communication of information for patients or health professionals via computers, internet, television and other digital means; Providing multiple use access to global computer information networks for the transfer and dissemination of information concerning scientific, biological, and medical research, research and development of new products, and health care; Providing internet chatroom and online forums featuring information concerning scientific, biological, and medical research, research and development of new products, and health care; Transmission of audiovisual information concerning scientific, biological, and medical research, research and development of new products, and health care via electronic communications networks

Educational services, namely, development and dissemination of printed and printed educational materials of others in the field of pharmaceuticals, vaccines, medicines, biologics, biotherapeutics and biosimilars; conducting seminars, live events for educational purposes, webinars, talk shows, web or television series, and production of podcasts all in the field of pharmaceuticals, vaccines, medicines, biologics, biotherapeutics and biosimilars; training services for patient support and education services in the nature of courses relating to prevention and treatment of medical disorders.

Printed matter, namely, newsletters, bulletins, magazines, periodicals, books, journals, pamphlets, posters, and stationery items in the nature of calendars, pens, pencils, notepads, writing pads, folios, stickers, bookmarks, pocket sized cards featuring information and messages, all in the field of health care, disease management, pharmaceuticals and medical developments.

Filing History

PARTIAL INVALIDATION OF REG EXT PROTECTION CREATED
Jun 22, 2026 INPR
FINAL DECISION TRANSACTION PROCESSED BY IB
Apr 16, 2026 FINO
FINAL DISPOSITION NOTICE SENT TO IB
Mar 27, 2026 FICS
FINAL DISPOSITION PROCESSED
Mar 27, 2026 FIMP
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Dec 16, 2025 FICR
NOTICE OF UPDATED REGISTRATION CONFIRMATION EMAILED
Nov 11, 2025 NURC
CORRECTION UNDER SECTION 7 - PROCESSED
Oct 22, 2025 COC.
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Oct 22, 2025 APRE
POST PUBLICATION AMENDMENT – NOT ENTERED
Oct 2, 2025 CHPN
ASSIGNED TO PETITION STAFF
Sep 18, 2025 APET
NOTICE OF REGISTRATION CONFIRMATION EMAILED
Sep 16, 2025 NRCC
REGISTERED-PRINCIPAL REGISTER
Sep 16, 2025 R.PR
TEAS POST PUBLICATION AMENDMENT RECEIVED
Jul 31, 2025 EPPA
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Jul 29, 2025 NPUB
PUBLISHED FOR OPPOSITION
Jul 29, 2025 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Jul 23, 2025 NONP
WITHDRAWN FROM PUB - OG REVIEW QUERY
Jun 24, 2025 PBCR
APPROVED FOR PUB - PRINCIPAL REGISTER
May 29, 2025 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
May 28, 2025 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
May 28, 2025 CRFA
TEAS REQUEST FOR RECONSIDERATION RECEIVED
May 28, 2025 ERFR
NOTIFICATION OF FINAL REFUSAL EMAILED
Apr 14, 2025 GNFN
FINAL REFUSAL E-MAILED
Apr 14, 2025 GNFR
FINAL REFUSAL WRITTEN
Apr 14, 2025 CNFR
TEAS/EMAIL CORRESPONDENCE ENTERED
Apr 11, 2025 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Apr 11, 2025 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Apr 11, 2025 TROA
ATTORNEY REVIEW COMPLETED
Mar 8, 2025 ATRV
PRELIMINARY/VOLUNTARY AMENDMENT - ENTERED
Feb 26, 2025 AMPX
TEAS VOLUNTARY AMENDMENT RECEIVED
Feb 26, 2025 PARI
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Jan 12, 2025 GNRN
NON-FINAL ACTION E-MAILED
Jan 12, 2025 GNRT
NON-FINAL ACTION WRITTEN
Jan 12, 2025 CNRT
PREVIOUS ALLOWANCE COUNT WITHDRAWN
Jan 6, 2025 ZZZX
WITHDRAWN FROM PUB - OG REVIEW QUERY
Dec 3, 2024 PBCR
APPROVED FOR PUB - PRINCIPAL REGISTER
Nov 14, 2024 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Nov 13, 2024 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Nov 13, 2024 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Nov 13, 2024 TROA
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
Nov 9, 2024 OPNX
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Oct 23, 2024 OPNS
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
Oct 23, 2024 OPNR
TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Oct 18, 2024 EWAF
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Oct 18, 2024 TCCA
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
Oct 18, 2024 ECDR
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Oct 18, 2024 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Oct 18, 2024 REAP
NOTIFICATION OF NON-FINAL ACTION E-MAILED
May 16, 2024 GNRN
NON-FINAL ACTION E-MAILED
May 16, 2024 GNRT
NON-FINAL ACTION WRITTEN
May 16, 2024 CNRT
TEAS/EMAIL CORRESPONDENCE ENTERED
Mar 18, 2024 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Mar 18, 2024 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Mar 18, 2024 TROA
REFUSAL PROCESSED BY IB
Oct 11, 2023 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Sep 20, 2023 RFCS
REFUSAL PROCESSED BY MPU
Sep 20, 2023 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Aug 31, 2023 RFCR
NON-FINAL ACTION WRITTEN
Aug 30, 2023 CNRT
ASSIGNED TO EXAMINER
Aug 24, 2023 DOCK
APPLICATION FILING RECEIPT MAILED
May 30, 2023 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
May 26, 2023 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
May 25, 2023 REPR